Program overview

Walking lunch

Time: 13:00 - 13:00

Session 2 – 2025 in review

Chairs: Paul van Schil, Xavier Geets and Birgit Weynand

Session 1 – Hot topic 2025: Immunotherapy for advanced NSCLC

Chairs: Prof. Dr. I. Demedts & Prof. Dr. J. Vansteenkiste

Targeted therapy & ADCs stage IV NSCLC

Time: 12:15 - 12:35

Take-home messages: stage I-III NSCLC

Time: 12:10 - 12:15

Unresectable NSCLC

Time: 11:50 - 12:10

Resectable NSCLC

Time: 11:30 - 11:50

Speaker t.b.a.

Pathology & biomarkers

Time: 11:15 - 11:30

Coffee break – Meet sponsors

Immunotherapy in special populations

Time: 10:20 - 10:40

Speaker t.b.c.

Cases second vote & take-home

Time: 10:15 - 10:20

Discussion (overall & Belgium)

Time: 10:00 - 10:15

Q&A

Time: 09:50 - 10:00

Recent news in next-line immunotherapy

Time: 09:35 - 09:50

Case: Next-line choices

Time: 09:30 - 09:35

Recent news in 1L immunotherapy

Time: 09:15 - 09:30

Closure

Time: 21:55 - 22:00

Controversies in stage IV EGFR mutated NSCLC

Time: 21:25 - 21:55

Stage II-III resectable NSCLC: how to make choices?

Time: 20:55 - 21:25

SLOW: Progress in non-metastatic SCLC at last!

Time: 20:05 - 20:35

FAST: 10Y phase 3 immunotherapy trials in stage IV NSCLC

Time: 19:35 - 20:05

Opening “Progress across all stages of NSCLC and SCLC”

Time: 19:30 - 19:35

Registration & Buffet

Time: 19:00 - 19:30

Closure

Time: 12:55 - 13:00

SCLC

Time: 12:35 - 12:55

Speaker t.b.a.

Cases: First-Line choices

Time: 09:10 - 09:15

Introduction

Time: 09:00 - 09:10

Welcome & Registration

Time: 08:30 - 08:30